A research team at the University of Lille in France has developed a...
- Proteomics device could speed up cancer surgery
- MIT researchers develop ingestible sensor to diagnose GI bleeding
- Portable malaria screening device capable of early-stage detection
- Imaging method reveals effects of treatment for mutant IDH1 gliomas
- Plug-and-play blocks may allow customisable diagnostics
MIT researchers develop ingestible sensor to diagnose GI bleeding
A team of researchers from the Massachusetts Institute of Technology (MIT) in the US has developed an ingestible sensor that features genetically engineered bacteria to diagnose bleeding in the stomach or other gastrointestinal (GI) problems.
Portable malaria screening device capable of early-stage detection
A team of researchers at the USC Viterbi School of Engineering in the US have developed a prototype for a portable device capable of early-stage malaria detection.
Ultromics secures funding to market AI heart diagnostics
UK-based diagnostic support tools developer Ultromics has secured £10m in funding during a Series A investment round led by Oxford Sciences Innovation (OSI).
Study indicates need to analyse fat deposits for metabolic diseases
A new body composition study by Swedish digital health company AMRA has revealed the need for examining fat distribution patterns in order to gain better insights into metabolic diseases and develop treatments for them.
Blood test helps to avoid unnecessary prostate cancer biopsies
A clinical validation study carried out by Cleveland Clinic has shown that using a new blood test called IsoPSA could have avoided 47% of biopsies performed to identify prostate cancer.
Imaging method reveals effects of treatment for mutant IDH1 gliomas
Researchers at Massachusetts General Hospital (MGH) in the US have used magnetic resonance spectroscopy (MRS) imaging to investigate the mechanisms behind a potential targeted treatment for gliomas.
Researchers devise new test to detect pancreatic cancer early
Researchers at the University of California, San Diego (UC San Diego) have developed a new blood test for early detection of pancreatic cancer in order to increase the chances of curative therapy.
Plug-and-play blocks may allow customisable diagnostics
Researchers at the Massachusetts Institute of Technology’s (MIT) Little Devices Lab have developed a set of modular building blocks that can be used to enable cheap, easy and customised diagnostic tools for a variety of diseases.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.